All Type of News
Boryung Pharm’s antihypertensive Kanarb family achieves over KRW 5 billion monthly sales
The Boryung Pharm’s ‘Kanarb(generic name: fimasartan) family,’ Korea’s first novel hypertension treatments, achieved KRW 5 billion monthly prescriptions.
The Boryung Pharm’s Kanarb family, including 4 drugs, such as ...
“The delay on the Tagrisso drug price negotiation is no special treatment”
While the drug price negotiation for ‘Tagrisso,’ a non-small cell lung cancer treatment, has made various issues, the National Health Insurance Service(NHIS) clarified them.
In a statement of clarifying them on the 2...
Medytox, “Daewoong should not distort essence of the trial”
Medytox(CEO Hyun-Ho Jung) strongly argued an essence of the trial involving the company and Daewoong Pharmaceutical is to reveal the truth if Daewoong Pharmaceutical pirated the company’s botulinum strain and manufact...
Daewoong, “They first need to verify sources of Meditoxin. They have no concrete proof”
The conflict between Medytox, which has had difficulties in entering the U.S. market, and Daewoong Pharmaceutical is getting serious.
As getting an actual dismissal of a civil case that Medytox filed against Daewoong...
Drug price cuts on large medicines including Lipitor on 1st next month
Large medicines, like Lipitor, Lyrica and Tamiflu, are going to have a drug price cut from 1 November. In the situation, the industry is paying attention to how parties interested will handle with balancing difference...
‘Serious’ polarization of R&D investment among innovative pharmaceutical companies
It was criticized polarization of R&D investments was getting intensified among innovative pharmaceutical companies certified to have excellent new drug development and overseas expansion capabilities.
While there is...
What are impacts of excluding national university hospitals for ‘MOHW’s adjustment of market price’
While inspections have been active as details for the market price adjustment is certain in the next year, the pharmaceutical field and the distribution industry have had mixed feelings over exclusion of national univ...
Daewoong’s 10 products including Olostar Tab receives 45-day administrative measures
Daewoong Pharmaceutical has taken a bunch of administrative measures of sales suspension on its major products for violating a public advertising prohibition regulation on ETC medicines.
The Ministry of Food and Drug...
NHIS criticized for ‘Delay on Tagrisso Drug Price Negotiation’ at National Assembly inspection
The delay on the Tagrisso’s drug price negotiation was criticized at the National Assembly inspection.
The Minjoo Party Rep. In-Soon Nam pointed out the problem to Sang-Cheol Sung, President of the National Health In...
NHIS incorrectly imposes KRW 2.299 trillion insurance contributions for past 5 years
As wrongly imposing insurance contributions to its policy holders, the National Health Insurance Service(NHIS) decided to refund KRW 2.299 trillion for the past 5 years, and the number of mistakes caused was increasin...
